The European Innovation Council (EIC) is inviting EIC Fund selected beneficiaries to join the next EIC ePitching on Cardiovascular or Respiratory Diseases, to take place on 15 February 2024. The selected EIC Fund companies will have the opportunity to pitch to a jury of top-level European investors from Amadeus Capital Partners, Apollo Health Venture, BioGeneration Ventures, Bionova Capital, Böhringer Ingelheim Venture Fund, Bullnet Capital, Capricorn Partners, Eleven Ventures, Hadean Ventures, High-Tech Gründerfonds, Indaco Venture Partners, Invivo Capital, Karista Ventures, Kurma Partners, MIG AG, Novo Holdings, Panakès Partners, Pathena Investments, Peppermint Venture Partners, Supernova Invest, Turenne Capital, V-Bio Ventures, Vesalius Biocapital, Ventura Biomed, Xange, Ysios Capital.
Submit your application before 5 December 2023
Apply for this opportunity now!
When filling out the form, please note that you should provide the information of the person attending the pitching session, as they will be featured in the event brochure.
Cardiovascular diseases are the leading cause of death in the EU, with respiratory diseases trailing not too far behind, in third place, in 2019. These conditions have a massive impact on European and Global Healthcare, and novel technologies to address them are essential.
The EIC ePitching on Cardiovascular or Respiratory Diseases on 15 February 2024 will turn the spotlight to the EIC-backed innovators developing solutions to tackle these conditions.
What’s in it for you?
If selected, EIC beneficiaries will get to pitch their innovations in front of some of the most qualified European investors, with the added benefit of receiving exclusive training and the possibility of being invited for one-to-one meetings and follow-up.
Don’t miss your chance to:
- Pitch your solution to top European VCs
- Receive one-to-one meeting requests from investors
- Benefit from top-tier coaching sessions
When?
15 February 2024, from 13:00 CET to 17:00 CET.
Where?
Online. Selected beneficiaries will receive a zoom link to join the session.
Who can apply?
The EIC companies selected for/having received the investment component and which are working on innovative solutions to tackle cardiovascular or respiratory diseases.
The eligible companies are:
- H2020 EIC Accelerator Pilot blended finance companies, which have received the grant and investment component;
- EIC Accelerator Horizon Europe companies selected for grant first, blended finance or investment only.
How can you be selected?
In order to qualify for selection, you must complete the application form. Please makes sure the information completed allows EIC to verify your eligibility for the call (I.e fill in correctly the project number, acronym).
Please note that your profile will be shared with the session’s jury members, which will base their selection according to the information you submitted, as well as their investment preferences. Any information you submit is also liable to be shared in an upcoming call for investors, as well as an event brochure.
If you have any objections to the use of your information or any questions regarding the event, please contact us through the email events@eicfund.eu.
Why is the EIC organizing this ePitching?
This opportunity is brought to you by the EIC Ecosystem Partnerships and Co-Investment Support Programme, which is expanding the EIC’s Business Acceleration Services (BAS). The programme includes a component to promote co-investment along with the EIC Fund, by preparing beneficiaries to interact with investors and connecting them through matchmaking and dedicated events. It is also supporting EIC innovators by creating a network of specialized, sector-focused EIC Partners to help them access the services they need.
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.